Qprotyn is a Delaware biotech corporation that has developed a cutting-edge, patented formulation technology for Viscosity Reduction of High Concentration mAbs using only 2-GRAS excipients. We enable innovator molecules and biosimilars for SubQ delivery with patentable, low volume – high concentration (>225mg/mL) formulations. Upgrade your IV mAb to SubQ with Qprotyn. Patients will thank you for getting under their skin.